Cargando…
Prevalence of impaired renal function and determinants in the southwest of Iran
BACKGROUND: Chronic kidney disease (CKD) is a growing global health problem with faster progression in developing countries such as Iran. Here we aimed to evaluate the prevalence and determinants of CKD stage III+. METHODS: This research is part of the Khuzestan Comprehensive Health Study (KCHS), a...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353841/ https://www.ncbi.nlm.nih.gov/pubmed/34376157 http://dx.doi.org/10.1186/s12882-021-02484-x |
_version_ | 1783736486496043008 |
---|---|
author | Alvand, Saba Abolnezhadian, Farhad Alatab, Sudabeh Mohammadi, Zahra Hayati, Fatemeh Noori, Mohammad Danehchin, Leila Paridar, Yousef Cheraghian, Bahman Rahimi, Zahra Hariri, Sanam Masoudi, Sahar Mard, Seyed Ali Shayesteh, Ali Akbar Poustchi, Hossein |
author_facet | Alvand, Saba Abolnezhadian, Farhad Alatab, Sudabeh Mohammadi, Zahra Hayati, Fatemeh Noori, Mohammad Danehchin, Leila Paridar, Yousef Cheraghian, Bahman Rahimi, Zahra Hariri, Sanam Masoudi, Sahar Mard, Seyed Ali Shayesteh, Ali Akbar Poustchi, Hossein |
author_sort | Alvand, Saba |
collection | PubMed |
description | BACKGROUND: Chronic kidney disease (CKD) is a growing global health problem with faster progression in developing countries such as Iran. Here we aimed to evaluate the prevalence and determinants of CKD stage III+. METHODS: This research is part of the Khuzestan Comprehensive Health Study (KCHS), a large observational population-based cross-sectional study in which 30,041 participants aged 20 to 65 were enrolled. CKD was determined with estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73m(2), based on two equations of Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). The multivariate logistic regression was used to evaluate the CKD stage III+ determinants. RESULTS: Prevalence of CKD stage III+ is estimated to be 7.1, 5.5, and 5.4% based on MDRD, CKD-EPI, and combination of both equations, respectively. More than 89% of CKD subjects aged higher than 40 years. In regression analysis, age more than 40 years had the strongest association with CKD stage III+ probability (OR: 8.23, 95% CI: 6.91–9.18). Higher wealth score, hypertension, High-Density Lipoprotein levels less than 40 mg/dl, and higher waist to hip ratio were all associated with CKD stage III+ while Arab ethnicity showed a protective effect (OR: 0.69, 95% CI: 0.57–0.78). CONCLUSION: Our findings provide detailed information on the CKD stage III+ and its determinants in the southwest region of Iran. Due to strong association between age and CKD stage III+, within a few decades we might expect a huge rise in the CKD prevalence. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02484-x. |
format | Online Article Text |
id | pubmed-8353841 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-83538412021-08-11 Prevalence of impaired renal function and determinants in the southwest of Iran Alvand, Saba Abolnezhadian, Farhad Alatab, Sudabeh Mohammadi, Zahra Hayati, Fatemeh Noori, Mohammad Danehchin, Leila Paridar, Yousef Cheraghian, Bahman Rahimi, Zahra Hariri, Sanam Masoudi, Sahar Mard, Seyed Ali Shayesteh, Ali Akbar Poustchi, Hossein BMC Nephrol Research BACKGROUND: Chronic kidney disease (CKD) is a growing global health problem with faster progression in developing countries such as Iran. Here we aimed to evaluate the prevalence and determinants of CKD stage III+. METHODS: This research is part of the Khuzestan Comprehensive Health Study (KCHS), a large observational population-based cross-sectional study in which 30,041 participants aged 20 to 65 were enrolled. CKD was determined with estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73m(2), based on two equations of Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). The multivariate logistic regression was used to evaluate the CKD stage III+ determinants. RESULTS: Prevalence of CKD stage III+ is estimated to be 7.1, 5.5, and 5.4% based on MDRD, CKD-EPI, and combination of both equations, respectively. More than 89% of CKD subjects aged higher than 40 years. In regression analysis, age more than 40 years had the strongest association with CKD stage III+ probability (OR: 8.23, 95% CI: 6.91–9.18). Higher wealth score, hypertension, High-Density Lipoprotein levels less than 40 mg/dl, and higher waist to hip ratio were all associated with CKD stage III+ while Arab ethnicity showed a protective effect (OR: 0.69, 95% CI: 0.57–0.78). CONCLUSION: Our findings provide detailed information on the CKD stage III+ and its determinants in the southwest region of Iran. Due to strong association between age and CKD stage III+, within a few decades we might expect a huge rise in the CKD prevalence. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02484-x. BioMed Central 2021-08-10 /pmc/articles/PMC8353841/ /pubmed/34376157 http://dx.doi.org/10.1186/s12882-021-02484-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Alvand, Saba Abolnezhadian, Farhad Alatab, Sudabeh Mohammadi, Zahra Hayati, Fatemeh Noori, Mohammad Danehchin, Leila Paridar, Yousef Cheraghian, Bahman Rahimi, Zahra Hariri, Sanam Masoudi, Sahar Mard, Seyed Ali Shayesteh, Ali Akbar Poustchi, Hossein Prevalence of impaired renal function and determinants in the southwest of Iran |
title | Prevalence of impaired renal function and determinants in the southwest of Iran |
title_full | Prevalence of impaired renal function and determinants in the southwest of Iran |
title_fullStr | Prevalence of impaired renal function and determinants in the southwest of Iran |
title_full_unstemmed | Prevalence of impaired renal function and determinants in the southwest of Iran |
title_short | Prevalence of impaired renal function and determinants in the southwest of Iran |
title_sort | prevalence of impaired renal function and determinants in the southwest of iran |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353841/ https://www.ncbi.nlm.nih.gov/pubmed/34376157 http://dx.doi.org/10.1186/s12882-021-02484-x |
work_keys_str_mv | AT alvandsaba prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT abolnezhadianfarhad prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT alatabsudabeh prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT mohammadizahra prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT hayatifatemeh prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT noorimohammad prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT danehchinleila prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT paridaryousef prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT cheraghianbahman prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT rahimizahra prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT haririsanam prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT masoudisahar prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT mardseyedali prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT shayestehaliakbar prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran AT poustchihossein prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran |